Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 700.18 million compared to CNY 619.72 million a year ago. Revenue was CNY 700.18 million compared to CNY 619.72 million a year ago.

Net income was CNY 327.22 million compared to CNY 274.59 million a year ago. Basic earnings per share from continuing operations was CNY 0.625 compared to CNY 0.5244 a year ago. Diluted earnings per share from continuing operations was CNY 0.625 compared to CNY 0.5244 a year ago.